Evidence map›Paper›PMID 27055870›Full record

ArticleLeukemia2016

Population-based analyses among 184 patients diagnosed with large granular lymphocyte leukemia in the Netherlands between 2001 and 2013.

A G Dinmohamed, M Brink, O Visser, M Jongen-Lavrencic

Registry-linked trialAbstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04453345 (The Efficacy of Thalidomide Plus Prednisone and Methotrexate for the Symptomatic Large Granular Lymphocytic Leukemia - a Prospective Multicenter Clinical Trial From China), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04453345 phase2 / phase3unknown statusnot on this map

The Efficacy of Thalidomide Plus Prednisone and Methotrexate for the Symptomatic Large Granular Lymphocytic Leukemia - a Prospective Multicenter Clinical Trial From China

TypeinterventionalSponsorInstitute of Hematology & Blood Diseases Hospital, ChinaRan2013 to 2025Enrolled42ConditionsT-LGL Leukemia, Clpd-NkArmsthalidomide + prednisone + methotrexate
3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Large granular lymphocytic leukemia: a brief review.American journal of blood research · 2022
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

A G DinmohamedDepartment of Research, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.
M BrinkDepartment of Research, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.
O VisserDepartment of Registration, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
M Jongen-LavrencicDepartment of Hematology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAged, 80 and overFemaleHumansIncidenceLeukemia, Large Granular LymphocyticMaleMiddle AgedNetherlandsRegistriesYoung Adult

Identifiers

PMID27055870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.